Leadership

Transforming Precision Medicine with AI-powered Pathology

Our team’s work is a unique collaboration of experienced AI technologists, physicians and exceptional healthcare research professionals.

Leadership Team

Avi Veidman

CEO, Co-Founder

Lotan Chorev

VP, Technology & Operations, Co-Founder

Ken Bloom, MD, FCAP

Head of Pathology

Grainger Greene

Head of Product

Byron Lawson

VP, Pharma BD & Strategic Partnerships

Sharon Elkobi

VP, Strategic Alliances & BD

Ettai Markovits, MD

Director of Biomedical Research

Elad Amsalem

VP, R&D

Hagar Sachs

Head of RA & QA

Board of Directors

Michael Pellini

Section 32

Nir Nimrodi

Chair of the Board

Cris De Luca

Sanofi Ventures

Noga Yerushalmi

M Ventures

Tom Gibbs

Debiopharm Innovation Fund

Scientific Advisors

Julian Adams, PhD

Stand Up To Cancer

President & CEO

Suzana Couto, PhD

Johnson & Johnson Innovative Medicine

Translational Safety Lead

Hossein Borghaei, MD

Fox Chase Cancer Center

Associate Member

Klaas Zuideveld

TECregen AG

CEO

Gal Markel

Clalit Health Services

Co-Founder & Chairman, Samueli Integrative Cancer Pioneering Institute